{"brief_title": "Buprenorphine and Naloxone Combination Study - 10", "brief_summary": "The purpose of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.", "detailed_description": "The objective of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.", "condition": "Opioid-Related Disorders", "intervention_type": "Drug", "intervention_name": "Buprenorphine/naloxone", "criteria": "Inclusion Criteria: Male/Female between the ages of 21 and 45. Within 15% of ideal body weight. No oral pathology that would interfere with the sublingual absorption of the medication. Experienced in the use of opiates but not dependent. Exclusion Criteria: LFT's exceeding than 3x's normal. History of seizure. Opiate dependent.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "50 Years", "healthy_volunteers": "No", "id": "NCT00015288.xml"}